Immunohistochemical detection of axillary lymph node micrometastases in node negative breast cancer patients using cytokeratin and epithelial membrane antigen

被引:8
作者
Choudhury, Monisha [1 ]
Agrawal, Sapna [1 ]
Pujani, Mukta [3 ]
Thomas, Shaji [2 ]
Pujani, Meenu [1 ]
机构
[1] Lady Hardinge Med Coll & Hosp, Dept Pathol, New Delhi, India
[2] Lady Hardinge Med Coll & Hosp, Dept Surg, New Delhi, India
[3] Hamdard Inst Med Sci & Res, New Delhi, India
关键词
Axillary node; breast cancer; cytokeratin; epithelial membrane antigen; micrometastases;
D O I
10.4103/2278-330X.149946
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objective: The study was conducted to detect occult metastases in lymph node negative breast cancer patients using cytokeratin (CK) and epithelial membrane antigen (EMA) immunohistochemistry (IHC) and correlate this with primary tumor size and grade. Materials and Methods: A total of 32 cases including 12 prospective and 20 retrospective cases of axillary lymph node negative breast cancer were studied. CK and EMA IHC were performed to detect micrometastases. Results: Axillary lymph node metastases were detected in 18.75% of previously node negative cases using CK and EMA IHC. CK was found to be more sensitive for detection of metastases compared to EMA. A highly significant correlation was observed between tumor grade and axillary lymph node metastases detected by CK and EMA. However, no significant correlation was found between tumor size and axillary lymph node metastases detected by IHC. Conclusion: In the present study, there was an increase of 18.75% in the occult metastases detection rate using CK and EMA. To conclude, IHC detection of occult metastases should be done using CK in all axillary node negative cases, especially in T1 and T2 stage tumors.
引用
收藏
页码:28 / 31
页数:4
相关论文
共 18 条
[1]  
[Anonymous], 1980, Br Med J, V281, P134
[2]   Outcomes of sentinel node biopsy for breast cancer in British Columbia, 1996 to 2001 [J].
Chua, B ;
Olivotto, IA ;
Donald, JC ;
Hayashi, AH ;
Doris, PJ ;
Turner, LJ ;
Cuddington, GD ;
Davis, NL ;
Rusnak, CH .
AMERICAN JOURNAL OF SURGERY, 2003, 185 (02) :118-126
[3]   Size of breast cancer metastases in axillary lymph nodes: Clinical relevance of minimal lymph node involvement [J].
Colleoni, M ;
Rotmensz, N ;
Peruzzotti, G ;
Maisonneuve, P ;
Mazzarol, G ;
Pruneri, G ;
Luini, A ;
Intra, M ;
Veronesi, P ;
Galimberti, V ;
Torrisi, R ;
Cardillo, A ;
Goldhirsch, A ;
Viale, G .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1379-1389
[4]   Role of immunohistochemical detection of lymph-node metastases in management of breast cancer [J].
Cote, RJ ;
Peterson, HF ;
Chaiwun, B ;
Gelber, RD ;
Goldhirsch, A ;
Castiglione-Gertsch, M ;
Gusterson, B ;
Neville, AM .
LANCET, 1999, 354 (9182) :896-900
[5]  
Edge SB, 2010, AJCC CANC STAGING MA, P347
[6]  
FISHER B, 1981, SURG GYNECOL OBSTET, V152, P765
[7]   DETECTION AND SIGNIFICANCE OF OCCULT METASTASES IN NODE-NEGATIVE BREAST-CANCER [J].
HAINSWORTH, PJ ;
TJANDRA, JJ ;
STILLWELL, RG ;
MACHET, D ;
HENDERSON, MA ;
RENNIE, GC ;
MCKENZIE, IFC ;
BENNETT, RC .
BRITISH JOURNAL OF SURGERY, 1993, 80 (04) :459-463
[8]  
Kohlberger P, 2001, ANTICANCER RES, V21, P697
[9]   A Prospective Study Comparing Touch Imprint Cytology, Frozen Section Analysis, and Rapid Cytokeratin Immunostain for Intraoperative Evaluation of Axillary Sentinel Lymph Nodes in Breast Cancer [J].
Krishnamurthy, Savitri ;
Meric-Bernstam, Funda ;
Lucci, Anthony ;
Hwang, Rosa F. ;
Kuerer, Henry M. ;
Babiera, Gildy ;
Ames, Fredrick C. ;
Feig, Barry W. ;
Ross, Merrick I. ;
Singletary, Eva ;
Hunt, Kelly K. ;
Bedrosian, Isabelle .
CANCER, 2009, 115 (07) :1555-1562
[10]  
Park K., 2005, PARKS TXB PREVENTIVE, P303